0 Comentários
0 Compartilhamentos
231 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Reels
-
Blogs
-
Marketplace
-
Offers
-
Jobs
-
Faça o login para curtir, compartilhar e comentar!
-
Biosimilar Bevacizumab Market – Oncology Cost Reduction and Access ExpansionMarket Overview The biosimilar bevacizumab market is transforming oncology care by offering substantially lower-cost alternatives to reference Avastin while maintaining equivalent efficacy and safety in treating colorectal, lung, breast, and glioblastoma cancers. Bevacizumab inhibits vascular endothelial growth factor, starving tumors of blood supply, but its high cost has limited access in...0 Comentários 0 Compartilhamentos 564 Visualizações 0 Anterior
-
From Bench to Bedside: The Expanding Role of Neuro-Oncology Drugs and CNS Tumor TreatmentThe translation of scientific discoveries into effective therapies for brain tumor patients depends on a robust pipeline of neuro-oncology drugs that can overcome the unique challenges of central nervous system malignancies. Neuro-oncology drugs have emerged as essential tools in this translation, providing the therapeutic agents needed to target tumor cells while minimizing damage to healthy...0 Comentários 0 Compartilhamentos 298 Visualizações 0 Anterior
-
Real World Evidence Solutions For Oncology Market Forecast for Advanced Oncology AnalyticsCancer research has traditionally depended heavily on controlled clinical trials, but the treatment experience that occurs outside those trials is generating an increasingly valuable source of evidence. Patients receive different therapies, move between care settings, respond differently to treatment, and experience outcomes over long periods that may not always be fully captured within...0 Comentários 0 Compartilhamentos 823 Visualizações 0 Anterior
-
The Precision Oncology Frontier: How the Hematological Malignancies Disease Market Is Advancing Blood Cancer CareBlood cancers, including leukemia, lymphoma, and myeloma, represent a significant and growing global health challenge. However, the treatment landscape for these malignancies is undergoing a profound transformation, moving from traditional chemotherapy towards more precise, targeted, and immune-based therapies. The Hematological Malignancies Disease Market, valued at USD 29.6 Billion in 2025,...0 Comentários 0 Compartilhamentos 418 Visualizações 0 Anterior
-
A Critical Barrier: How Oncology Safety Equipment Is Enhancing Cancer CareOncology safety equipment is an essential component of cancer care, ensuring that healthcare workers can deliver chemotherapy and other treatments safely and effectively. This equipment, including chemotherapy gowns, gloves, and closed-system transfer devices, protects healthcare professionals from the hazardous drugs they handle daily, supporting their health and well-being. According to...0 Comentários 0 Compartilhamentos 646 Visualizações 0 Anterior
-
Advancing Canine Mast Cell Tumors Treatment: The Growing Veterinary Oncology MarketThe field of veterinary oncology has witnessed remarkable progress in recent years, with increased attention focused on the diagnosis and treatment of cancer in companion animals. Among the most common and challenging cancers in dogs are mast cell tumors, which represent a significant area of focus for veterinary oncologists and pharmaceutical developers. The canine mast cell...0 Comentários 0 Compartilhamentos 451 Visualizações 0 Anterior
-
Advancing PD-1 Inhibitor Therapy: The Growing Immuno-oncology Drugs MarketThe field of oncology has been revolutionized by the development of immuno-oncology drugs, with PD-1 inhibitors emerging as a cornerstone of cancer treatment. Tislelizumab, a novel PD-1 inhibitor, offers a targeted approach to immunotherapy, enhancing the body's immune response against cancer cells. The PD-1 inhibitor therapy market is experiencing remarkable growth, with projections...0 Comentários 0 Compartilhamentos 240 Visualizações 0 Anterior
-
AI in Oncology Market Trends: Digital Pathology and AI-Powered Cancer AnalysisPolaris Market Research today announced findings from its latest report, projecting the global AI in Oncology market to grow from USD 6.51 billion in 2025 to USD 56.44 billion by 2034, at a CAGR of 27.1%. The report profiles 10 leading companies across multiple market segments, benchmarking the global AI in oncology landscape across component, application, and regional lines. The market covers...0 Comentários 0 Compartilhamentos 106 Visualizações 0 Anterior
-
Anti-CD31 Antibody: Advancing Research and Diagnostics in Vascular Biology and OncologyThe Anti-Cd31 Antibody Market represents a specialized segment of the life sciences research and diagnostics industry, driven by the critical role of CD31 as a marker for endothelial cells, angiogenesis, and vascular biology. This market encompasses monoclonal and polyclonal antibodies, conjugated and unconjugated formats, and associated reagents designed to support applications including...0 Comentários 0 Compartilhamentos 125 Visualizações 0 Anterior
-
Bcl-2 (B-Cell Lymphoma 2) Inhibitors Market – Targeted Apoptosis Therapy Advancing Oncology CareMarket Overview Cancer treatment continues to advance through therapies that restore the body's natural cell death mechanisms in malignant cells. The Bcl-2 (B-Cell Lymphoma 2) Inhibitors Market is growing as oncologists incorporate Bcl-2 inhibitor therapies into treatment regimens for hematologic malignancies where cancer cells evade normal apoptotic signaling. Hematology-oncology centers...0 Comentários 0 Compartilhamentos 380 Visualizações 0 Anterior
-
Beyond Antigens: The Expanding Role of mRNA and Personalized Vaccines in the Oncology MarketThe global oncology market is witnessing a significant paradigm shift towards highly personalized, technology-driven therapeutic approaches. The mRNA and Personalized Cancer Vaccines in the Oncology Market represents a critical and rapidly evolving segment, driven by the need to overcome tumor heterogeneity and deliver tailored treatments. With the overall cancer vaccines market...0 Comentários 0 Compartilhamentos 347 Visualizações 0 Anterior
-
Companion Diagnostics Market Growth Through Biomarker-Guided TreatmentThe companion diagnostics market is becoming an increasingly important link between diagnosis and treatment. Instead of asking only whether a disease is present, modern healthcare is increasingly asking a more specific question: which therapy is most appropriate for this patient? That change is reshaping the role of diagnostics. A biomarker can now influence whether a targeted drug is...0 Comentários 0 Compartilhamentos 741 Visualizações 0 Anterior
-
Antibodies Market Expands as Pharmaceutical R&D Investment RisesThe Antibodies Market is projected to grow from USD 256.1 billion in 2026 to USD 489.8 billion by 2036 at a 6.7% CAGR. ROCKVILLE, MD — October 6, 2026 — The Antibodies Market is projected to reach USD 489.8 billion by 2036, rising from USD 256.1 billion in 2026 at a CAGR of 6.7%, according to Fact.MR. The market was valued at approximately USD 240.0 billion in 2025 and is expected...0 Comentários 0 Compartilhamentos 10 Visualizações 0 Anterior
-
Chemotherapy at Home Services Market: Home Cancer Care TrendsChemotherapy at Home Services Market: Growth, Trends, Demand & Forecast to 2034 Chemotherapy at Home Services Market Snapshot The Chemotherapy at Home Services Market is emerging as an important segment of decentralized cancer care, supported by the growing demand for convenient treatment options, advances in home healthcare infrastructure, and increasing interest in...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Clinical Oncology Next Generation Sequencing Market: Emerging Technologies and Business OpportunitiesPolaris Market Research has published insightful research on Clinical Oncology Next Generation Sequencing Market. The research report offers an in-depth analysis of the market, covering all the major aspects, including market size, market share, growth drivers, and key trends. Besides, a thorough assessment of the annual forecast, strategies, and potential roadmaps has been provided in the...0 Comentários 0 Compartilhamentos 993 Visualizações 0 Anterior
-
Daratumumab Injection Market: Competitive Landscape, Strategic Collaborations, and the Rise of Subcutaneous FormulationsThe Daratumumab Injection Market is a dynamic and highly competitive sector characterized by intense research and development activities, strategic collaborations, and a relentless pursuit of innovation. As the market is projected to reach USD 7.0 billion by 2035, growing at a CAGR of 10.1%, key players are actively seeking to differentiate themselves through advanced product...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
DNA Sequencing Market: Global Demand & Industry Outlook 2033DNA Sequencing Market: Growth, Trends, Demand & Forecast to 2033 The DNA Sequencing Market is experiencing strong growth as sequencing technologies become more affordable, accurate, and scalable. The declining cost of sequencing, expanding applications in precision medicine and oncology, increasing genomic research, and technological advancements in high-throughput sequencing are...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Epidermal Growth Factor Receptor Inhibitor Market Growth Drivers and Investment OpportunitiesThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Europe Prostate Cancer Devices Market Growing at 6.9% CAGR 2025-2030 ReportAccording to a new report from Intel Market Research, the Europe prostate cancer devices market was valued at USD 567.8 million in 2024 and is projected to grow from USD 605.0 million in 2025 to USD 845.6 million by 2030, exhibiting a robust CAGR of 6.9% during the forecast period (2025–2030). This growth is driven by an aging male population with a higher risk profile, continuous...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Europe Prostate Cancer Devices Market Growing at 6.9% CAGR 2025-2030 ReportAccording to a new report from Intel Market Research, the Europe prostate cancer devices market was valued at USD 567.8 million in 2024 and is projected to grow from USD 605.0 million in 2025 to USD 845.6 million by 2030, exhibiting a robust CAGR of 6.9% during the forecast period (2025–2030). This growth is driven by an aging male population with a higher risk profile, continuous...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
Páginas impulsionada
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek